Munich, Germany – July 8, 2025
Xpedite Diagnostics has officially launched the SwiftX™ Validation Program, a competitive opportunity designed to support early-career researchers working in infectious disease, molecular diagnostics, and related fields. As part of the program, selected participants will receive up to €2500 travel grant to attend and present at ESCMID Global 2026, one of the most prestigious congresses in clinical microbiology and infectious diseases.
In addition to the grant, selected researchers will gain free access to Xpedite’s advanced SwiftX™ DNA extraction kits and receive personalized technical support throughout their validation projects.
“We believe the next big leap in diagnostics can come from today’s young scientists,” said Dr. Stephen Hennart, Head of Operations at Xpedite Diagnostics. “Through this program, we’re helping promising researchers turn ideas into evidence and evidence into impact.”
Program Highlights:
- Up to €2500 Travel Grant for ESCMID 2026 (Munich)
- Free SwiftX™ kits (cfDNA, Sepsis, or DNA Water)
- Technical support throughout the project
- Invitation to a pre-ESCMID seminar at Xpedite HQ
The SwiftX™ Validation Program is open to early-career researchers working with challenging sample matrices such as plasma, serum, wastewater, or whole blood, in fields including:
- Liquid biopsy and cfDNA
- Infectious disease diagnostics
- Antimicrobial resistance
- Wastewater-based epidemiology
- Sepsis and clinical microbiology
Applicants are required to submit a brief project description, research objectives, and timeline for execution (planned for Q3-Q4 2025). Only 10 research projects will be selected based on feasibility and scientific relevance.
Application Deadline: July 31, 2025
Interested researchers can apply now by completing the application form HERE.
For questions or inquiries, please contact: info@xpedite-dx.com